Background: Previous studies indicate that platelets and leucocytes might contribute to the development of neointimal hyperplasia following arterial injury. The present study was aimed at further investigating the role of platelets and leucocytes, alone or in combination, in promoting vascular smooth muscle cell (SMC) proliferation in vitro, focusing on the relative contribution of different soluble growth factors released by these cells, and on the ability to induce proto-oncogene expression, such as c-fos. Methods: SMCs from rabbit aortas, made quiescent by serum deprivation, were stimulated with either activated platelets, leucocytes, or both, separated from SMCs by a 3 membrane insert. SMC proliferation was evaluated by measuring the incorporation of H-thymidine. The relative contribution of different platelet-derived mediators to SMC growth was evaluated by adding either ketanserin, a 5-HT receptor antagonist, R68070, a TxA 2 2 receptor antagonist, BN52021, a platelet activating factor (PAF) receptor antagonist, and trapidil, a platelet derived growth factor (PDGF) receptor antagonist. The role of different leucocyte sub-populations (neutrophils and monocytes1lymphocytes) was also determined in additional experiments. Results: SMC proliferation was significantly increased by activated platelets to 36069% of control values (P,0.05). This effect was reduced by ketanserin, R68070, BN 52021 or trapidil. Whole leucocytes, neutrophils or lymphocytes1 monocytes also increased SMC proliferation with respect to control experiments. Simultaneous stimulation of SMCs by platelets and whole leucocytes was associated with a significant greater increase in SMC proliferation as compared to SMC stimulated with platelets or leucocytes alone. c-fos expression, almost undetectable in unstimulated SMCs, was markedly increased by activated platelets or leucocytes. Conclusions: Activated platelets promote SMC proliferation in vitro via release of soluble mediators, including serotonin, thromboxane A PAF and PDGF; activated leucocytes also induce a significant SMC proliferation and exert an additive effect when 2 activated together with platelets; SMCs stimulated with activated platelets and leucocytes show an early expression of the proto-oncogene c-fos.
Introduction
and technical factors associated with an increased risk of restenosis, our understanding of the problem still remains Vascular smooth muscle cell (SMC) proliferation almost incomplete. Previous studies have shown that the arterial invariably occurs in response to vessel injury, and is injury caused by angioplasty leads to activation and local thought to be one of the key events responsible for the adhesion of platelets and leucocytes [2] [3] [4] [5] [6] . Both platelets occurrence of restenosis in patients after successful corand leucocytes, once activated, can release a number of onary angioplasty [1] . However, despite an extensive growth factors, all of which may in turn stimulate SMC number of studies examining the clinical, morphologic, proliferation and migration [1] . Indeed, experimental studies in animal models have suggested a pathophysiological role for platelets as well as for 2.2. Experimental set up leucocytes in contributing to the occurrence of restenosis [7] [8] [9] [10] [11] . Although these studies directly support the imporAfter harvesting, SMCs were washed with PBS, manualtance of platelets and leucocytes in modulating SMC ly counted in a hemocytometer and subcultured into 24-growth and migration, the mechanisms through which well culture plates in DMEM containing 10% FCS for 24 h 4 these effects are obtained are incompletely understood. In at an initial density of 5310 cells per well. An equal particular, little is known about the relative contribution of number of SMCs was plated in each well to exclude different platelet and leucocyte-derived growth factors, and variation due to differences in cell number. Twenty-four the molecular mechanisms involved in this process. Thus, hours later, SMCs were made quiescent by incubation in the aim of the present study was to further investigate the fresh DMEM containing 0.1% FCS for 72 h [13] . After 72 role of platelets and leucocytes, alone or in combination, in h of serum deprivation, a plastic cylinder, closed at the promoting vascular SMC proliferation in vitro, focusing on bottom with a microporous membrane (0.2 mm diameter, TM the relative contribution of different soluble growth factors Transwell ), Becton Dickinson, Bedford, MA) was inreleased by these cells, and on the ability to induce serted into each well. The height of the transwell was such proto-oncogene expression, such as c-fos, the induction of that it did not reach the bottom of the well containing the which is one of the earliest events associated with cell SMC layers, leaving them undisturbed (Fig. 1) . A platelet proliferation.
and / or leucocyte suspension was added into each transwell. Platelets and leucocytes were then activated as described below in Section 2.4. This set-up permitted free passage of soluble mediators through the microporous 2. Methods membrane to the SMC culture medium, but did not allow direct cell-cell interaction ( Fig. 1 On the day of the experiment, venous blood was previously described [12] . Briefly, thoracic aortas were obtained from healthy donors who had not taken any dissected and cleaned of connective tissue under sterile medication for at least 2 weeks before the studies. For conditions. Vascular rings of about 2 cm in length were cut isolating platelets, blood was collected into Vacutainer longitudinally and the endothelium was removed by gently tubes containing 3.8% sodium citrate (9:1 v / v) and rubbing the inner layer of the vessel with a sterile blade.
centrifuged at 1203g for 20 min at room temperature to The muscular layers obtained were cut into 2-mm strips, obtain platelet-rich plasma (PRP). PRP was removed and placed onto 100-mm tissue culture dishes with the intimal centrifuged again at 10003g for 5 min to obtain plateletside oriented toward the bottom of the culture dish and poor plasma (PPP). The platelet count in the PRP was covered with a small volume of Dulbecco's Modified adjusted to 300 000 / ml by dilution with PPP as needed. Eagles Medium (DMEM) supplemented with 10% heatThe PRP was kept at room temperature and used within 1 inactivated calf serum (FCS), 100 units per ml penicillin h. and 100units per ml streptomycin. The vessels were Peripheral blood leucocytes from healthy donors were maintained in a humidified incubator (95% air-5% CO ) prepared by Ficoll-Hypaque gradient centrifugation from 2 at 378C. DMEM was replaced after 24 h and then every heparinized venous blood followed by dextran sedimentathree days. After about 7 days, SMCs started to migrate tion, as previously described [14] . Briefly, blood samples from vessel segments to the surrounding bottom of the were mixed with 6% dextran (1 / 1, v / v) and the red blood culture dish. Confluent primary cultures were removed from culture dishes by brief exposure to 0.3% trypsin / 0.02% EGTA (ethyleneglycol-bis-(b-aminoethylether)N,N,N9,N9-tetraacetic acid) and passaged at a 1:3 split ratio. Cells between the second and seventh passage were used for all studies.
At confluence, when examined with phase-contrast microscopy, the cells displayed the typical hill-and-valley appearance of SMC cultures and grew to form multilayers. In addition, cells were identified by immunocytochemical cells were allowed to settle at room temperature for 90 fMLP (1 mM)1Zymosan (0.2 mg / ml). After 30 min of min. The white cell rich supernatant was placed over stimulation, transwells with leucocyte suspensions were standard Ficoll-Hypaque separation media and centrifuged removed from culture wells and SMCs were maintained as at 4003g for 30 min at room temperature. The gradient described above to evaluate cell proliferation. obtained after centrifugation allowed the isolation of To determine the contribution of oxygen free radicals neutrophils (pellet) from monocytes / lymphocytes (upper released by activated neutrophils in promoting SMC interface). Any contaminating red cells were lysed with 1 proliferation, transwells were filled with a neutrophil vol of H O for 30 s followed by addition of 2.7% saline.
suspension as above. Five min after neutrophil activation, 2 Leucocytes were then washed in Hanks balanced salt superoxide dismutase (SOD, 1000 U / ml) and catalase solution, resuspended in phosphate-buffered saline (PBS), (2000 U / ml), were added to SMC culture medium. After counted and immediately used. The neutrophil count was 30 min of stimulation, transwells with neutrophil suspenadjusted to 1500 cells per ml, while the monocyte / lymphosion were removed from culture wells and SMCs were cyte count was adjusted to 1000 cells per ml. The purity of maintained as described above to evaluate cell proliferthe neutrophil and lymphocyte / monocyte preparations was ation. checked by microscopy and found to be .99% and .95%, Finally, to study the role of platelets and leucocytes respectively.
together in promoting SMC proliferation, in another set of experiments, SMCs were simultaneously challenged with 2.4. Experimental protocol platelets and whole leucocytes activated as described.
To investigate the effects of activated platelet on SMC 2.5. Evaluation of SMC proliferation proliferation, 500 ml of PRP were added to each transwell (see Section 2.2) and platelets were activated with 60 mg
The growth effects of blood cells on SMC proliferation 3 of collagen (from calf skin, monomeric, acid-soluble form; were quantified by measuring the extent of H-thymidine Sigma cat.885-1) under mechanical stirring. After 30 min, incorporation into cell DNA. After the 30-min stimulation transwells containing PRP with activated platelets were period with platelets and / or leucocytes, SMCs were incuremoved from culture wells and SMCs were maintained in bated at 378C for 24 h. Thereafter, SMCs were pulsed with 3 a humidified incubator (95% air-5% CO ) at 378C for the 1 mCi H-thymidine and after 24 additional hours, the 2 later assessment of the degree of cell proliferation. Since culture medium was discarded, cells were rinsed twice SMCs were kept under conditions of serum deprivation, with PBS and lysed with 0.2% perchloric acid. The any proliferating activity should be related to activated contents of the wells were aspirated and wells rinsed an platelets. To determine the relative contribution of the additional time with PBS, and the acid-precipitated cellular different mediators released by activated platelets, transmaterial was solubilized with 0.5 ml 0.01 N sodium wells were filled with PRP and platelets were activated as hydroxide-0.1% sodium dodecyl sulphate. The content of above. Five min after platelet activation, either one of the each well was added to 7 ml of Optifluor and radioactivity following compounds were added to the SMC culture was measured with a Beckman beta-scintillator. Incorpora- ent antagonists was chosen on the basis of preliminary To verify that the observed increase in H-thymidine experiments which showed that this concentration caused a incorporation is actually related to an increase in the maximal effect on inhibition of proliferation in response to absolute number of SMCs, additional control experiments the respective agonist alone.
were performed. Cells were grown in 100-mm Petri dishes. In another set of experiments, the effects of whole At confluence, cells were washed with PBS and harvested leucocytes and of different leucocyte subtypes in promotwith 0.3% trypsin / 0.02% EGTA diluted in PBS, as ing SMC proliferation was investigated. Five hundred ml described above. Cells were manually counted in a of the following suspensions were added to the transwells:
hemocytometer before and 48 h after serum deprivation (a) whole leucocytes; (b) neutrophils; (c) monocytes to-(negative control), or after stimulation with 10% FCS or gether with lymphocytes. A concentration of 1 mM of activated platelets, as described above. N-formylmethionyl-leucyl-phenylalanine (fMLP) or 0.2 mg / ml of Zymosan was used to activate neutrophils or 2.6. Proto-oncogene expression monocytes / lymphocytes, respectively, while the whole leucocyte suspension was activated with a mixture of To determine whether activated platelets and leucocytes Tris, pH 7.6, 0.8 M NaCl, 0.5% sodium dodecyl sulphate vated platelets caused a marked increase in H-thymidine (SDS), 53Denhardt's solution, 40% deionized formamide, incorporation in SMCs up to 360629% of the value 10% dextran sulphate, 0.1% sodium pyrophosphate, and 75 observed in quiescent cells ( Fig. 2A) . Similar results were g / ml of salmon sperm DNA for at least 4 h at 428C. obtained using washed platelets resuspended in PBS (data Hybridization was performed at 428C for 20 h using the not shown). Addition of unstimulated platelets (no col-32 same buffer containing a P-labeled fos probe,1.06 kb Pst lagen) or collagen alone (no platelets) into the transwells Of note is the finding that when all antagonists were added experimental condition (including positive and negative together, an even more pronounced antiproliferative effect controls) were performed. For proto-oncogene expression was observed (Fig. 2B) . studies, 24 wells from each experimental condition were
In another set of experiments, the effects of activated pooled together and used for one Northern Blot analysis. A whole leucocytes on SMC proliferation were evaluated. total of three different blots were performed. A one-way Activated leucocytes also caused a significant increase in 3 ANOVA was used to evaluate differences in cell proliferof H thymidine incorporation up to 210621% of the ation among different experimental conditions, followed, values observed in negative control experiments (Fig. 3A) . whenever a F value was found significant, by a Students Similar results were obtained when SMCs were stimulated t-test for unpaired observations with the Bonferronis with neutrophils alone or with monocytes1lymphocytes correction. A P-value ,0.05 was considered significant. (Fig. 3A) . When both platelets and leucocytes were used to 3 stimulate SMCs, a marked increase in H-thymidine incorporation was observed, which was significantly great-3. Results er than that observed with either cell type alone (Fig. 3A) . The role of oxygen free radicals released by activated 3.1. Effects of activated platelets and leucocytes on neutrophils in promoting SMC proliferation was evaluated SMC proliferation in vitro by adding SOD and catalase to culture medium. SOD and 3 catalase significantly reduced H-thymidine incorporation The effects of activated platelets and leucocytes on SMC as compared to SMCs stimulated with neutrophils alone in proliferation were assessed on SMCs made quiescent by the absence of scavengers (P,0.05, Fig. 3B ). serum deprivation. Thus, any proliferative effect seen Absolute cell counts revealed that under conditions of In contrast, addition of serum to the medium resulted in a marked increase in c-fos mRNA levels (FCS 10%). Activated platelets and leucocytes together induced an increase in c-fos mRNA levels (platelets1 leucocytes) which were significantly greater than the levels observed with platelets or leucocytes alone. The insert shows a typical Northern blot experiment. *5P,0.05 vs. leucocytes. undetectable in unstimulated, quiescent SMCs (negative additive effect when activated together with platelets. (3) controls). In contrast, addition of serum to the medium SMCs stimulated with activated platelets and leucocytes (positive controls) resulted in a marked increase in c-fos
show an early expression of the proto-oncogene c-fos . The mRNA levels (Fig. 4) . Interestingly, activated platelets or intensity of c-fos expression is correlated with the degree leucocytes induced an increase in c-fos mRNA levels of SMC proliferation.
3 which paralleled the increase in H-thymidine incorporaThat platelet-derived mediators might play an important tion (Fig. 4) . Of note is the finding that stimulation with role in contributing to the development of neointimal platelets and leucocytes together caused a greater increase hyperplasia following arterial injury is not a novel concept. in c-fos mRNA levels with respect to those observed with For example, previous studies have shown that serotonin leucocytes alone (P,0.05; Fig. 4) . demonstrated that within 30 min of balloon injury, platelet factor IV, one of the constituents of the a-granules, can be The main findings of the present study are: (1) Activated detected throughout the intima and media [24] . Because platelets promote SMC proliferation in vitro via release of platelet factor IV and other platelet-derived substances, like soluble mediators, including serotonin, thromboxane PDGF, serotonin, and ADP reside in the same granule A platelet-activating factor (PAF), and platelet-derived population and are secreted in response to the same 2 growth factor (PDGF); among these, PDGF seems to exert stimuli, it is likely that these substances also enter the the most significant proliferating activity. (2) Activated vessel wall after balloon injury [24] . Prompted by these leucocytes (both neutrophils and monocytes1lymphocytes) indirect observations, several studies have been conducted also induce a significant SMC proliferation and exert an to determine whether antiplatelet interventions might be able to reduce the extent of the neointimal hyperplasia that species, which have been shown to stimulate SMC growth follows balloon angioplasty. While some of these studies and proto-oncogene expression [34] . However, the finding have shown that activated platelets play an important role of the present study that SOD and catalase inhibit neutroin the pathophysiology of neointimal hyperplasia [8, 9] , phil-induced SMC proliferation by about 50% indicate that others have reported negative results [25] . In addition, other neutrophil-related mediators might be involved in clinical studies employing different antiplatelet regimens this phenomenon. More direct evidence supporting the role have consistently shown failure of these treatments in of circulating leucocytes in promoting neointimal hyperreducing the incidence of restenosis after successful corplasia following arterial injury have been recently reported onary angioplasty (for a review see Ref. [26] ).
by our group and by others. In those studies, administra-A possible explanation for this discrepancy might be tion of a monoclonal antibody against the leucocyte CD11 / found in the data from the present study. Indeed, we have CD18 adhesion complex or against its ligand expressed on shown that collagen-activated platelets (a stimulus that did the membrane of vascular cell, ICAM-1, was associated not exert any effect on SMC proliferation per se), were with a significant reduction in leucocyte infiltration into the capable of inducing a marked proliferation of SMCs in arterial wall, ultimately leading to a reduction in neointiculture. This phenomenon occurred through the release of mal hyperplasia [10, 11] . several soluble growth factors, since the experimental set Data from the present study extend these previous up used in the present study did not allow a direct cell-toobservations and indicate that both neutrophils and monocell interaction, but it only permitted free passage of cytes / lymphocytes are able to promote SMC proliferation soluble mediators. The relative contribution of some of the in vitro although probably through different mechanisms. substances released upon platelet activation on SMC More interestingly, however, the present study indicates proliferation was evident when specific receptor antagothat an additive interaction exists between platelets and nists were added to the culture medium. When SMCs were leucocytes in this phenomenon. Indeed, when SMCs were stimulated with activated platelets in the presence of either challenged with both activated platelets and leucocytes, a ketanserin, R68070, or BN52021, a similar reduction in significant higher degree of cell proliferation was ob-SMC proliferation was observed. Addition of trapidil, a served, as compared to platelets or leucocytes alone. triazolopyrimidine with PDGF receptor antagonistic propFinally, the present study has focused on the molecular erties, resulted in a significant greater decrease in SMC mechanisms responsible for platelet and leucocyte-induced proliferation, as compared to the other antagonists used, SMC proliferation. Northern blot analyses of mRNA indicating a more prominent role for PDGF in modulating isolated from SMCs challenged with activated platelets and this phenomenon. More important, however, is the obleucocytes showed that an early expression of the c-fos servation that when all antagonists were added together, an proto-oncogene occurs in these cells. The proto-oncogenes even more marked decrease in SMC proliferation was were first identified as unexpected sequences of vertebrate observed, demonstrating that activated platelets stimulate genomic DNA corresponding to the acutely transforming SMC growth through the release of several different genes of RNA tumor viruses [35, 36] . A set of protomediators, each of which separately contributes to stimuoncogenes, whose prototypes are c-fos, c-myb, and c-jun, late cell growth. Thus, if one interferes with only one of encode for proteins that are rapidly induced by growth these platelet-derived mediators, SMC growth might be stimuli, are found within the cell nucleus, and may be left practically unaffected; this might explain why clinical obligatory for proliferation and other growth factor effects trials employing these types of pharmacological intervento occur [35] . Transient expression of these proto-ontions have consistently reported negative results.
cogenes is triggered by diverse trophic signals such as Another possible cellular source of growth factors that growth factors, physiological stress, and activity-dependent might be involved in the pathophysiology of neointimal events [36, 37] . Most importantly, it has been shown that hyperplasia following angioplasty is represented by circuinterventions that introduce complementary 'antisense' lating leucocytes. Circulating leucocytes are known to oligonucleotides into cells, which bind and decrease the activate and accumulate at the site of vascular injury both abundance of 'sense' mRNA transcripts, can markedly in experimental models and in the clinical setting; furtherinhibit expression of selected oncogene proteins. For more, certain leucocyte subtypes, such as monocytes and example, blocking c-myb expression by antisense techlymphocytes, are known to contain numerous growth niques inhibits neointimal hyperplasia in balloon-injured factors in their cytoplasm, including PDGF [27] , Epiderrat carotid arteries [38] , thus demonstrating the importance mal Growth Factor [28] , basic Fibroblast Growth Factor of proto-oncogene expression in leading to the formation [29] , Transforming Growth Factor type [30] , PAF [31] , of neointimal lesions following arterial damage. In our Tumor Necrosis Factor [32] , and interleukin-1 [33] . In study, the activation of the nuclear oncogene c-fos addition, neutrophils may also be involved in triggering occurred in SMCs challenged with activated platelets, cell proliferation, even though these cells do not contain leucocytes, or both. Although SMCs stimulated with both growth factors in their cytoplasm. Indeed, neutrophils are activated platelets and leucocytes showed a c-fos exprescapable of producing large amounts of active oxygen sion greater than that observed in SMCs stimulated with
